Search

Your search keyword '"Jones, Michael E."' showing total 266 results

Search Constraints

Start Over You searched for: Author "Jones, Michael E." Remove constraint Author: "Jones, Michael E." Database Unpaywall Remove constraint Database: Unpaywall
266 results on '"Jones, Michael E."'

Search Results

1. Concurrent RB1 Loss and BRCA-Deficiency Predicts Enhanced Immunological Response and Long-Term Survival in Tubo-Ovarian High-Grade Serous Carcinoma

2. BMI and breast cancer risk around age at menopause

4. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts

6. Utility of polygenic risk scores in UK cancer screening: a modelling analysis

7. The C-Band all-sky survey (C-BASS): New constraints on the integrated radio spectrum of M 31

8. Cancer incidence and mortality in 23 000 patients with type 1 diabetes in the UK: Long‐term follow‐up

9. Hypertensive conditions of pregnancy, preterm birth, and premenopausal breast cancer risk: a premenopausal breast cancer collaborative group analysis

10. Supplementary Table 1 from The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)

11. Supplementary Table 1 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

12. Data from The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)

13. Supplementary Table 2 from The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)

14. Supplementary Table 2 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

15. Supplementary Table 2 from The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)

16. Supplementary Figure 1 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

17. Supplementary Figure 2 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

18. Supplementary Figure 3 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

19. Supplementary Figure Legends from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

20. Supplementary Figure 4 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

21. Supplementary Figure 4 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

22. Data from The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

23. Supplementary Table 2 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

24. Table S1 from The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

25. Supplementary Figure Legends from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

26. Supplementary Table 1 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

27. Supplementary Figure 3 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

28. Supplementary Figure 2 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

29. Supplementary Table 1 from The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)

30. Supplementary Figure 1 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

31. Table S1 from The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

32. Data from The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)

33. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

34. Prevalence of Hypertension among Children Based on the New American Academy of Pediatrics Clinical Practice Guidelines

35. Limitations of Polygenic Risk Scores for Stratified Cancer Screening: A UK Modelling Study

36. Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts

37. Psychological and psychiatric problems

41. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women

42. The value of interleukin levels in the diagnosis of febrile urinary tract infections in children and adolescents; a systematic review and meta-analysis

43. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas

46. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

47. Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3)

48. Psychological and psychiatric problems

49. Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma

Catalog

Books, media, physical & digital resources